Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 137 B, Issue 1, 2005, Pages 36-39

  Serretti, Alessandro ^a,b,c   Cusin, Cristina ^a,b   Benedetti, Francesco ^a,b   Mandelli, Laura ^a   Pirovano, Adele ^a   Zanardi, Raffaella ^a,b   Colombo, Cristina ^a,b   Smeraldi, Enrico ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bipolar disorder; Circadian rhythm; CLOCK gene; Insomnia; Major depressive disorder; Pharmacogenetics

Indexed keywords

ANTIDEPRESSANT AGENT; FLURAZEPAM; FLUVOXAMINE; GENOMIC DNA; LITHIUM; PAROXETINE; PINDOLOL; PLACEBO;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CIRCADIAN RHYTHM; CLINICAL FEATURE; CLINICAL TRIAL; CLOCK GENE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; FEMALE; GENE; GENOTYPE; HAMILTON SCALE; HOMOZYGOSITY; HUMAN; HUMAN CELL; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLUVOXAMINE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; MULTIVARIATE ANALYSIS; PAROXETINE; PINDOLOL; POLYMORPHISM, GENETIC; SEROTONIN ANTAGONISTS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS; TRANS-ACTIVATORS; TREATMENT OUTCOME;

EID: 23044441089     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30130     Document Type: Article

References (25)

1. Bech P, Malt U, Dencker S, Ahlfors U, Elgen K, Lewander T, Lundell A, Simpson G, Lingjaerde O. 1993. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 87(Suppl 372):37-40.
2. Bellini L, Gatti F, Gasperini M, Smeraldi E. 1992. A comparison between delusional and non-delusional depressives. J Affect Disord 25:129-138.
3. Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E, Smeraldi E. 2003. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet 123B:23-26.
4. Bunney WE, Bunney BG. 2000. Molecular clock genes in man and lower animals: Possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22:335-345.
5. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey. Lawrence Erlbaum Associates, pp 8-14.
6. Desan PH, Oren DA, Malison R, Price LH, Rosenbaum J, Smoller J, Charney DS, Gelernter J. 2000. Genetic polymorphism at the CLOCK gene locus and major depression. Am J Med Genet 96:418-421.
7. Gasparini P, Estivill X, Volpini V, Totaro A, Castellvi-Bel S, Govea N, Mila M, Della Monica M, Ventruto V, De Benedetto M, Stanziale P, Zelante L, Mansfield ES, Sandkuijl L, Surrey S, Fortina P. 1997. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. Eur J Hum Genet 5:83-88.
8. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
9. Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, Mignot E. 1998. A CLOCK polymorphism associated with human diurnal preference. Sleep 21:569-576.
10. King DP, Vitaterna MH, Chang AM, Dove WF, Pinto LH, Turek FW, Takahashi JS. 1997. The mouse Clock mutation behaves as a antimorph and maps within the W19H deletion, distal of Kit. Genetics 146:1049-1060.
11. Lahiri DK, Nurnberger JIJ. 1991. A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res 19:5444.
12. Lucca A, Lucini V, Catalano M, Alfano M, Smeraldi E. 1994. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. Neuropsychobiology 29:108-111.
13. Mignone F, Gissi C, Liuni S, Pesole G. 2002. Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004.
14. Reinink E, Bouhuys AL, Gordijn MC, Van Den Hoofdakker RH. 1993. Prediction of the antidepressant response to total sleep deprivation of depressed patients: Longitudinal versus single day assessment of diurnal mood variation. Biol Psychiatry 34:471-481.
15. Reppert S, Weaver D. 2001. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647-676.
16. Robilliard DL, Archer SN, Arendt J, Lockley SW, Hack LM, English J, Leger D, Smits MG, Williams A, Skene DJ, Von Schantz M. 2002. The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects. J Sleep Res 11:305-312.
17. Savov A, Angelicheva D, Balassapoulou A, Jordanova A, Noussia-Arvanitakis S, Kalaydjieva L. 1995. Double mutant alleles: Are they rare? Hum Mol Genet 4:1169-1171.
18. Serretti A, Zanardi R, Rossini D, Cusin C, Lilli R, Smeraldi E. 2001. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry 6:586-592.
19. Serretti A, Benedetti F, Mandelli L, Lorenzi C, Pirovano A, Colombo C, Smeraldi E. 2003. Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet 121B:39-43.
20. Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M. 1998. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511.
21. Smeraldi E, Benedetti F, Barbini B, Campori E, Colombo C. 1999. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression - A placebo-controlled trial. Neuropsychopharmacology 20:380-385.
22. Sobin CA, Sackeim H. 1997. Psychomotor symptoms of depression. Am J Psychiatry 154:4-17.
23. Steeves TD, King DP, Zhao Y, Sangoram AM, Du F, Bowcock AM, Moore RY, Takahashi JS. 1999. Molecular cloning and characterization of the human clock gene: Expression in the suprachiasmatic nuclei. Genomics 57:198-200.
24. Wehr TA, Sack DA, Norman E. 1987. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 144:201-204.
25. Zanardi R, Benedetti F, DiBella D, Catalano M, Smeraldi E. 2000. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene. J Clin Psychopharmacol 20:105-107.